Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
Completed · Phase 1/Phase 2
Conditions studied: Kidney Cancer
In brief
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of biological therapy plus chemotherapy in treating patients with metastatic or recurrent kidney cancer.
Key facts
- Study ID
- NCT00003585
- Run by
- University of New Mexico
- People needed
- 35
- Starts
- 1996-08-01
- Expected to finish
- 2002-08-01
- Last updated by the study team
- 2013-12-10
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of New Mexico Cancer Research & Treatment Center — Albuquerque, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.